(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NDIFF

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NDIFF

ST13

US500000079032681

Class

1, 5

Filing

79032681

Registration

3418528

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

12/14/2018

Trademark type

Word

Nice classes

1, 5

Filing date

08/31/2006

Registration date

04/29/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/27/2018

Last transaction

01/27/2018

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Shiga, JP

Examiner

KAJUBI, ELIZABETH N

Law office

L70

Current location

TMEG LAW OFFICE 107

Holders and representatives

Holders

TAKARA BIO INC.
Stem Cell Sciences Holdings Limited
Stem Cell Sciences Holdings Limited

Representatives

Tracy-Gene G. Durkin Sterne, Kessler, Goldstein & Fox P.L.L.C.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagents for scientific use in biological processing; biological preparations for scientific use in cell cultures; cultures of cell media for scientific use; media in the nature of buffer and standard solutions used in analytical chemistry for cell culture for use in scientific laboratories; media in the nature of buffer for scientific use; diagnostic preparations for scientific useantibodies; ELISA test kitsbiological reagents for use in enzyme linked immunosorbent assays for the biochemical detection of substances for scientific use; productskits containing antibodies for scientific use; tissue culture reagents for scientific and medical research use; cell culture reagents for scientific and medical research use; biological test kits composed of buffer and standard solutions used in analytical chemistryvectorscells and reagents for scientific and medical research use; cell culture media in the nature of buffer and standard solutions for scientific use

Class 5

Biological reagents for medical use in embryology; biological reagents for medical purposes in the field of molecular biology; reagents for use in biological processing for medical purposes; reagents for use in biological processing for veterinary purposes; agents in the nature of hormonescytokinesantigens and immunoglobulins for activating cellular functions ; biological preparations for use in cell cultures for medical purposes; antitoxic sera; antitoxic sera for in-vivo use for medical purposes; antibodies for the treatment of disease; antibodies for immunodiagnostic medical purposes; antibodies for immunoprophylatic medical purposes; antibodies for immunotherapeutic medical purposes; antibodies for in-vivo use in detecting diseases in livestock; immunological antibodies for medical use; ELISA test kitsbiological reagents for use in enzyme linked immunosorbent assays for the biochemical detection of substances for medical and medical laboratory use; tissue culture reagents for medical and medical laboratory use; cell culture media in the nature of buffer and standard solutions for medical and medical laboratory use

Publications

History of USPTO decisions and trademark events.

52 publications found

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

12/14/2018

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

10/01/2018

INPC

INVALIDATION PROCESSED

10/01/2018

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

09/27/2018

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

01/27/2018

PRAN

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED

01/27/2018

71AG

REGISTERED-SEC.71 ACCEPTED

01/27/2018

71AF

REGISTERED-SEC.71 FILED

01/25/2018

ES75

TEAS SECTION 71 & 15 RECEIVED

01/25/2018

CHLD

CHANGE OF OWNER RECEIVED FROM IB

08/31/2017

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

04/29/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/24/2016

RNWL

INTERNATIONAL REGISTRATION RENEWED

10/01/2016

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

07/10/2013

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

07/10/2013

715F

REGISTERED - SEC. 71 & SEC. 15 FILED

07/10/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/10/2013

ES75

TEAS SECTION 71 & 15 RECEIVED

07/05/2013

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/22/2012

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/18/2008

FIMP

FINAL DISPOSITION PROCESSED

08/18/2008

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/31/2008

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/29/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

04/29/2008

PUBO

PUBLISHED FOR OPPOSITION

02/12/2008

NPUB

NOTICE OF PUBLICATION

01/23/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/07/2008

ALIE

ASSIGNED TO LIE

01/07/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/19/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/17/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/17/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/17/2007

CPRA

PRIORITY ACTION MAILED

08/23/2007

CPRA

PRIORITY ACTION WRITTEN

08/23/2007

CNEA

EXAMINERS AMENDMENT MAILED

08/16/2007

XAEC

EXAMINER'S AMENDMENT ENTERED

08/15/2007

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/15/2007

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/01/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/01/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/01/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/01/2007

ATRV

ATTORNEY REVIEW COMPLETED

03/02/2007

RFNT

REFUSAL PROCESSED BY IB

02/23/2007

CREV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

02/12/2007

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

02/08/2007

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/01/2007

RFRR

REFUSAL PROCESSED BY MPU

02/01/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/01/2007

CNRT

NON-FINAL ACTION WRITTEN

01/31/2007

DOCK

ASSIGNED TO EXAMINER

01/24/2007

NWAP

NEW APPLICATION ENTERED

01/05/2007

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/28/2006

Continuous trademark protection

Get notified about every new filing that threatens NDIFF or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.